Ionotropic glutamate receptor subtypes in the aged memory-impaired and unimpaired Long-Evans rat

Neuroscience

Volumn 74, Issue 2, 1996, Pages 349-363

  Jeune, H Le ^a   Cecyre D ^a   Rowe, W ^a,b   Meaney, M J ^a,b   Quirion, R ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

aging; AMPA; ionotropic excitatory amino acid receptors; kainate; N methyl D aspartate; spatial memory

Indexed keywords

AMPA RECEPTOR; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID RECEPTOR; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBTYPE;

ADOLESCENT; AGED; AGING; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; MALE; MAZE TEST; NONHUMAN; OCCIPITAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; SPATIAL MEMORY; TASK PERFORMANCE;

EID: 0030593431     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00213-8     Document Type: Article

References (83)

1. Barnes C.A. Aging and the physiology of spatial memory. Neurobiol. Aging. 9:1988;563-568.
2. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
3. Gage F.H., Chen K.S., Buzsaki G., Armstrong D. Experimental approaches to age-related cognitive impairments. Neurobiol. Aging. 9:1988;645-655.
4. Gallagher M., Pelleymounter M. Spatial learning deficits in old rats: a model for memory decline in the aged. Neurobiol. Aging. 9:1988;549-556.
5. Rapp P.R., Amaral D.G. Individual differences in the cognitive and neurobiological consequences of normal aging. Trends Neurosci. 15:1992;340-345.
6. Björklund A., Dunnett S.B. Acetylcholine revisited. Nature. 375:1995;446.
7. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
8. Dunnett S.B., Fibiger H.C. Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia. Prog. Brain Res. 98:1993;413-420.
9. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci. 14:1991;220-223.
10. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
11. Winkler J., Suhr S.T., Gage F.H., Thal L.J., Fisher L.J. Essential role of neocortical acetylcholine in spatial memory. Nature. 375:1995;484-487.
12. Francis P.T., Sims N.R., Procter A.W., Bowen D.M. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. J. Neurochem. 60:1993;1589-1604.
13. Greenamyre J.T., Young A.B. Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging. 10:1989;593-602.
14. Jansen K., Faull R., Dragunow M., Synek B. Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors - an autoradiographic study. Neuroscience. 39:1990;613-627.
15. Markowska A.L., Sonte W.S., Ingram D.K., Reynolds J., Gold P.E., Conti L.H., Pontecorvo M.J., Wenk G.L., Olton D.S. Individual differences in aging: behavioral and neurobiological correlates. Neurobiol. Aging. 10:1989;31-43.
16. Parent A., Rowe W., Meaney M.J., Quirion R. Increased production of inositol and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors. J. Pharmac. exp. Ther. 272:1995;1110-1116.
17. Rossor M., Iversen L.L. Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease. Br. med. Bull. 42:1986;70-74.
18. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-38.
19. Collingridge G.L., Bliss T.V.P. NMDA receptors - their role in long-term potentiation. Trends Neurosci. 10:1987;288-293.
20. Harris E.W., Ganong A., Cotman C.W. Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res. 323:1984;132-137.
21. Morris R.G.M. Synaptic plasticity and learning: selective impairment of learning in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J. Neurosci. 9:1989;3040-3057.
22. Morris R.G.M., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature. 319:1986;774-776.
23. Cotman C.W., Bridges R.J., Taube J.S., Clark A.S., Geddes J.W., Monaghan D.T. The role of the NMDA receptor in central nervous system plasticity and pathology. J. NIH Res. 1:1989;65-74.
24. Olney J.W. Excitatory transmitter neurotoxicity. Neurobiol. Aging. 15:1994;259-260.
25. Fagg G.E., Foster A.C. Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience. 9:1983;701-729.
26. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42:1984;1-11.
27. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. A. Rev. Pharmac. Toxic. 29:1989;365-402.
28. Jorgensen M., Tygesen C.K., Andersen P.H. Ionotropic glutamate receptors - focus on non-NMDA receptors. Pharmac. Toxic. 76:1995;312-319.
29. Monaghan D. T. (1993) Autoradiographic analysis of excitatory amino acid receptors. In Receptor Autoradiography: Principles and Practice (eds Wharton J. and Polak J. M.), pp. 171-193. Oxford Scientific Publications, Oxford.
30. Schoepp D.D., Conn P.J. Metabotropic glutamate receptors in brain function and pathology. Trends pharmac. Sci. 14:1993;13-19.
31. Seeburg P.H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16:1993;359-365.
32. Collingridge G.L., Lester R.A.J. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmac. Rev, 40:1989;143-210.
33. Cotman C.W., Monaghan D.T., Ottersen O.P., Storm-Mathisen J. Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci. 10:1987;273-280.
34. Magnusson K.R., Cotman C.W. Age-related changes in excitatory amino acid receptors in two mouse strains. Neurobiol. Aging. 14:1993;197-206.
35. Bonhaus D.W., Perry W.B., McNamara J.O. Decreased density, but not number, of N-methyl-D-aspartate, glycine and phencyclidine binding sites in hippocampus of senescent rats. Brain Res. 532:1990;82-86.
36. Clark A.S., Magnusson K.R., Cotman C.W. In vitro autoradiography of hippocampal excitatory amino acid binding in aged Fisher 344 rats: relationship to performance on the Morris water maze. Behav. Neurosci. 106:1992;324-335.
37. Ingram D.K., Garofalo P., Spangler E.L., Mantione C.R., Odano I., London E.D. Reduced density of NMDA receptors and increased sensitivity to dizocilpine-induced learning impairment in aged rats. Brain Res. 580:1992;273-280.
38. Kito S., Miyoshi R., Nomoto T. Influence of age on NMDA receptor complex in rat brain studied by in vitro autoradiography. J. Histochem. Cytochem. 38:1990;1725-1731.
39. Miyoshi R., Kito S., Doudou N., Nomoto T. Influence of age on N-methyl-D-aspartate antagonist binding sites in the rat brain studied by in vitro autoradiography. Synapse. 8:1991;212-217.
40. Tamaru M., Yoneda Y., Ogita K., Shimizu J., Nagata Y. Age-related of N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res. 542:1991;83-90.
41. Wenk G.L., Walker L.C., Price D.L., Cork L.C. Loss of NMDA, but not GABA-A, binding in the brains of aged rats and monkeys. Neurobiol. Aging. 12:1991;93-98.
42. 3H]-kainate receptor binding in the hippocampal formation of aged Long-Evans rats. Hippocampus. 3:1993;269-277.
43. Nicolle M. M., Bizon J. and Gallagher M. (1995) In vitro autoradiography of glutamate receptors in aged rat striatum: a patch/matrix analysis and correlation with behavioral status. J. Neurosci. in press.
44. Miyoshi R., Kito S., Doudou N., Nomoto T. Effect of age on α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) binding sites in the rat brain studied by in vitro autoradiography. Neurochem. Res. 16:1991;849-854.
45. Keller E.A., Borghese C.M., Carrer H.F., Ramirez O.A. The learning capacity of high or low performance rats is related to the hippocampus NMDA receptors. Brain Res. 576:1992;162-164.
46. 3H-CPP binding and spatial learning deficits in aged rats. Psychobiology. 18:1990;298-304.
47. Wenk G.L., Grey C.M. Retention of maze performance inversely correlates with N-methyl-D-aspartate receptor number in hippocampus and frontal neocortex in the rat. Behav. Neurosci. 103:1989;688-690.
48. Geddes J.W., Ulas J., Brunner L.C., Choe W., Cotman C.W. Hippocampal excitatory amino acid receptors in elderly, normal individual and those with Alzheimer' disease: non-N-methyl-D-aspartate receptors. Neuroscience. 50:1992;23-34.
49. Greenamyre J.T., Penney J.B., Young A.B., D'Amato C.J., Hicks S.P., Shoulson I. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Science. 227:1985;1496-1499.
50. 3H]MK-801 binding in Alzheimer's disease. J. Neurochem. 53:1989;698-704.
51. Ulas J., Weihmuller F.B., Brunner L.C., Joyce J.N., Marshall J.F., Cotman C.W. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. J. Neurosci. 14:1994;6317-6324.
52. Issa A.M., Rowe W., Gauthier S., Meaney M.J. Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J. Neurosci. 10:1990;3247-3254.
53. Morris R.G.M. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Meth. 11:1984;47-60.
54. Aubert I., Rowe W., Meaney M.J., Gauthier S., Quirion R. Cholinergic markers in aged cognitively impaired Long-Evans rats. Neuroscience. 67:1995;277-292.
55. Quirion R., Wilson A., Rowe W., Aubert I., Richard J., Doods H., Parent A., White N., Meaney M. Facilitation of acetylcholine release and cognitive performance by an M2-muscarinic receptor antagonist in aged memory impaired rats. J. Neurosci. 15:1995;1455-1462.
56. 3H]MK-801 binding sites determined by quantitative autoradiography in rat brain. Neuroscience. 40:1991;533-543.
57. 3H]-kainic acid binding sites in rat CNS as determined by autoradiography. Brain Res. 252:1982;91-100.
58. Ulas J., Brunner L.C., Geddes J.W., Choe W., Cotman C.W. N-Methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease. Neuroscience. 49:1992;45-61.
59. Represa A., Duyckaerts D., Trembly E., Hauw J.J., Ben-Ari Y. Is senile dementia of the Alzheimer type associated with hippocampal plasticity? Brain Res. 457:1988;355-359.
60. Staubli U., Rogers G., Lynch G. Facilitation of glutamate receptors enhances memory. Proc. natn. Acad. Sci. U.S.A. 91:1994;777-781.
61. Barnes C.A. Normal aging: regionally specific changes in hippocampal synaptic transmission. Trends Neurosci. 17:1994;13-18.
62. Barnes C.A., Rao G., Foster T.C., McNaughton B.L. Region-specific age effects on AMPA sensitivity: electrophysiological evidence for synaptic contacts in hippocampal field CA1. Hippocampus. 2:1992;457-468.
63. Arai A., Lynch G. Factors regulating the magnitude of long-term potentiation induced by theta pattern stimulation. Brain Res. 598:1992;173-184.
64. Davies S.N., Lester R.A.J., Reymann K.G., Collingridge G.L. Temporally distinct pre- and post-synaptic mechanisms maintain long-term potentiation. Nature. 338:1989;500-503.
65. 2: a necessary step in long-term potentiation? Proc. natn. Acad. Sci. U.S.A. 88:1991;1893-1917.
66. Porter R.H.P., Greenamyre J.T. Regional variations in the pharmacology of AMPA receptors as revealed by receptor autoradiography. Brain Res. 664:1994;202-206.
67. Pagliusi S.R., Gerrard P., Abdallah M., Talabot O., Catsicas S. Age-related changes in expression of AMPA-selective glutamate receptor subunits: is calcium-permeability altered in hippocampal neurons? Neuroscience. 61:1994;429-433.
68. Dewar D., Chalmers D.T., Graham D.I., McCulloch J. Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus. Brain Res. 553:1991;58-64.
69. Garcia-Ladona F.J., Palacios J.M., Probst A., Wieser H.G., Mengod G. Excitatory amino acid AMPA receptor mRNA localization in several regions of normal and neurological disease affected human brain. An in situ hybridization histochemistry study. Molec. Brain Res. 21:1994;75-84.
70. Schoepp D.D., Sacaan A.I. Metabotropic glutamate receptors and neuronal degenerative disorders. Neurobiol. Aging. 15:1994;261-263.
71. Sugiyama H., Ito I., Hirono C. A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature. 325:1987;531-533.
72. Krzywkowski P., Lagny-Pourmir I., Jazat F., Lamour Y., Epelbaum J. The age-related increase in galanin binding sites in the rat brain correlates with behavioral impairment. Neuroscience. 59:1994;599-607.
73. Matsuoka N., Yamazaki M., Yamaguchi I. Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers. Neuroscience. 66:1995;617-626.
74. O'Steen W.K., Spencer R.L., Bare D.J., McEwen B.S. Analysis of severe photoreceptor loss and Morris water-maze performance in aged rats. Behav. Brain Res. 68:1995;151-158.
75. Raiteri M. Functional studies of neurotransmitter receptors in human brain. Life Sci. 54:1994;1635-1648.
76. 2 muscarinic receptors. J. Pharmac. exp. Ther. 248:1989;1255-1260.
77. Raiteri M., Leardi R., Marchi M. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release from rat brain. J. Pharmac. exp. Ther. 238:1984;209-214.
78. 2 "cardiac" muscarinic receptors. Eur. J. Pharmac. 177:1990;181-187.
79. Levey A.I., Edmunds S.M., Koliatsos V., Wiley R.G., Heilman C.J. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J. Neurosci. 15:1995;4077-4092.
80. Mrzljak L., Levey A.I., Golman-Rakic P.S. Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission. Proc. natn. Acad. Sci. U.S.A. 90:1993;5194-5198.
81. Weiss J.H., Yin H.-Z., Choi D.W. Basal forebrain cholinergic neurons are selectively vulnerable to AMPA/kainate receptor-mediated neurotoxicity. Neuroscience. 60:1994;659-664.
82. Stenvers K. L., Lund P. K. and Gallagher M. (1995) Increased expression of type 1 insulin-like growth factor receptor messenger RNA in rat hippocampal formation is associated with aging and behavioral impairment. Neuroscience in press.
83. Wellman C.L., Sengelaub D.R. Alterations in dendritic morphology of frontal cortical neurons after basal forebrain lesions in adult and aged rats. Brain Res. 669:1995;48-58.